tiprankstipranks
Trending News
More News >
Vor Biopharma (VOR)
NASDAQ:VOR
US Market
Advertisement

Vor Biopharma (VOR) Stock Statistics & Valuation Metrics

Compare
910 Followers

Total Valuation

Vor Biopharma has a market cap or net worth of $263.50M. The enterprise value is -$38.26K.
Market Cap$263.50M
Enterprise Value-$38.26K

Share Statistics

Vor Biopharma has 126,683,110 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding126,683,110
Owned by Insiders
Owned by Institutions

Financial Efficiency

Vor Biopharma’s return on equity (ROE) is -1.21 and return on invested capital (ROIC) is -94.31%.
Return on Equity (ROE)-1.21
Return on Assets (ROA)-0.82
Return on Invested Capital (ROIC)-94.31%
Return on Capital Employed (ROCE)-0.98
Revenue Per Employee0.00
Profits Per Employee-735.31K
Employee Count159
Asset Turnover0.00
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of Vor Biopharma is ―. Vor Biopharma’s PEG ratio is ―.
PE Ratio
PS Ratio
PB Ratio
Price to Fair Value0.79
Price to FCF
Price to Operating Cash Flow-2.21
PEG Ratio

Income Statement

In the last 12 months, Vor Biopharma had revenue of 0.00 and earned -116.91M in profits. Earnings per share was -1.70.
Revenue0.00
Gross Profit-3.53M
Operating Income-121.19M
Pretax Income-116.91M
Net Income-116.91M
EBITDA-113.39M
Earnings Per Share (EPS)-1.70

Cash Flow

In the last 12 months, operating cash flow was -113.60M and capital expenditures -489.00K, giving a free cash flow of -114.09M billion.
Operating Cash Flow-113.60M
Free Cash Flow-114.09M
Free Cash Flow per Share-0.90

Dividends & Yields

Vor Biopharma pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta4.26
52-Week Price Change132.56%
50-Day Moving Average1.85
200-Day Moving Average1.10
Relative Strength Index (RSI)49.33
Average Volume (3m)5.38M

Important Dates

Vor Biopharma upcoming earnings date is Mar 19, 2026, Before Open (Confirmed).
Last Earnings DateAug 7, 2025
Next Earnings DateMar 19, 2026
Ex-Dividend Date

Financial Position

Vor Biopharma as a current ratio of 5.19, with Debt / Equity ratio of 0.00%
Current Ratio5.19
Quick Ratio5.19
Debt to Market Cap0.00
Net Debt to EBITDA0.44
Interest Coverage Ratio0.00

Taxes

In the past 12 months, Vor Biopharma has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00

Enterprise Valuation

Vor Biopharma EV to EBITDA ratio is -0.23, with an EV/FCF ratio of -0.26.
EV to Sales0.00
EV to EBITDA-0.23
EV to Free Cash Flow-0.26
EV to Operating Cash Flow-0.26

Balance Sheet

Vor Biopharma has $200.56M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$200.56M billion.
Cash & Marketable Securities$200.56M
Total Debt$0.00
Net Cash-$200.56M
Net Cash Per Share-$1.58
Tangible Book Value Per Share$1.41

Margins

Gross margin is -53.77%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin-53.77%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%

Analyst Forecast

The average price target for Vor Biopharma is $1.18, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$1.18
Price Target Upside-41.00% Downside
Analyst ConsensusHold
Analyst Count4
Revenue Growth Forecast
EPS Growth Forecast-686.13%

Scores

Smart Score6
AI Score33
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis